Endoscopic Devices - Spain | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Spain is anticipated to reach US$560.50m in 2024.
The revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 6.52%, which will lead to a market volume of US$768.80m by 2029.
In a global context, the majority of revenue will be produced the United States, with a forecasted amount of US$10.39bn in 2024.
Spain's healthcare system is increasingly adopting advanced endoscopic devices, driven by a rising demand for minimally invasive procedures and improved patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Spain is experiencing moderate growth, influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and a growing emphasis on minimally invasive procedures among healthcare providers and patients alike.

Customer preferences: Consumers in Spain are increasingly favoring minimally invasive surgical options, reflecting a cultural shift towards prioritizing quicker recovery times and reduced hospital stays. This trend is further fueled by the aging population, which is more inclined to seek less invasive treatments for chronic conditions. Additionally, there is a growing awareness of the benefits of endoscopic procedures, leading to increased demand for advanced technologies that enhance patient safety and comfort. Healthcare providers are responding to these preferences by investing in innovative endoscopic devices, aligning with the evolving lifestyle factors of their patients.

Trends in the market: In Spain, the Endoscopic Devices Market is experiencing a notable shift towards advanced minimally invasive surgical techniques, driven by patient preferences for shorter recovery periods and reduced hospital stays. This trend is amplified by an aging population increasingly seeking efficient solutions for chronic conditions. Healthcare providers are investing in cutting-edge endoscopic technologies that enhance patient safety and comfort, reflecting a broader commitment to improving surgical outcomes. As awareness of these benefits grows, industry stakeholders must adapt to evolving patient demands and innovate accordingly to remain competitive in this dynamic market.

Local special circumstances: In Spain, the Endoscopic Devices Market is shaped by a robust healthcare system that emphasizes public access to advanced medical technologies. The country's diverse geography presents unique challenges, with rural areas often lacking specialized medical facilities, prompting a greater reliance on minimally invasive procedures to reduce travel and recovery times. Additionally, cultural attitudes favoring personalized care and patient involvement in treatment decisions further drive demand for innovative endoscopic solutions. Regulatory support for health technology assessments ensures that only effective devices reach the market, fostering a competitive landscape focused on quality and safety.

Underlying macroeconomic factors: The Endoscopic Devices Market in Spain is significantly influenced by macroeconomic factors including national economic health, healthcare funding, and global economic trends. Spain's stable economic recovery post-pandemic has led to increased public and private investment in healthcare, enhancing the availability of advanced endoscopic technologies. Furthermore, favorable fiscal policies aimed at improving healthcare infrastructure support the integration of innovative medical devices. The rising prevalence of gastrointestinal and respiratory diseases, coupled with an aging population, further amplifies demand for minimally invasive procedures, driving growth in the endoscopic sector.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.